Trial intelligence / Profile preview

Abraxane and Cisplatin in Advanced Nasopharyngeal Carcinoma

NCT01735409Phase 2Unknown

Sponsor
Sun Yat-sen University
Start
Nov 2012
Primary completion
Mar 2014
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of nab-paclitaxel in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Status: unknown.

02

Drugs

nab-paclitaxel
03

Conditions

nasopharyngeal carcinoma (NPC)

Beyond the preview

Go deeper on NCT01735409.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01735409.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call